Alaska Permanent Fund’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Alaska Permanent Fund's ABBV Position: Q2 2025 in Review
Alaska Permanent Fund sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 66,245 shares — an estimated $12.9M sold.
Alaska Permanent Fund first reported a position in ABBV in Q1 2020 and held it in 20 quarters. The position peaked at $13.1M in Q3 2024. 3,789 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.
- Alaska Permanent Fund reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
- Alaska Permanent Fund sold 66,245 AbbVie shares in Q2 2025, an estimated $12.9M.
- Alaska Permanent Fund first reported a position in AbbVie in Q1 2020 and held it in 20 quarters.
- Alaska Permanent Fund's AbbVie position peaked at $13.1M in Q3 2024.
- 3,789 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.
Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.